Literature DB >> 16697896

Peptide deformylase inhibitors.

Kelly Aubart1, Magdalena Zalacain.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16697896     DOI: 10.1016/S0079-6468(05)44403-3

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  7 in total

1.  A profiling platform for the identification of selective metalloprotease inhibitors.

Authors:  Christophe Antczak; Constantin Radu; Hakim Djaballah
Journal:  J Biomol Screen       Date:  2008-03-18

2.  Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.

Authors:  Jennifer Hoover; Thomas Lewandowski; Robert J Straub; Steven J Novick; Peter DeMarsh; Kelly Aubart; Stephen Rittenhouse; Magdalena Zalacain
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

3.  Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.

Authors:  Sharon Min; Karen Ingraham; Jianzhong Huang; Lynn McCloskey; Sarah Rilling; Anne Windau; Jason Pizzollo; Deborah Butler; Kelly Aubart; Linda A Miller; Magdalena Zalacain; David J Holmes; Karen O'Dwyer
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

4.  Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322.

Authors:  Karen O'Dwyer; Meredith Hackel; Sarah Hightower; Daryl Hoban; Samuel Bouchillon; Donghui Qin; Kelly Aubart; Magdalena Zalacain; Deborah Butler
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

5.  Potent sub-MIC effect of GSK1322322 and other peptide deformylase inhibitors on in vitro growth of Staphylococcus aureus.

Authors:  Deborah Butler; Dongzhao Chen; Karen O'Dwyer; Thomas Lewandowski; Kelly Aubart; Magdalena Zalacain
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

6.  Staphylococcus aureus formyl-methionyl transferase mutants demonstrate reduced virulence factor production and pathogenicity.

Authors:  Thomas Lewandowski; Jianzhong Huang; Frank Fan; Shannon Rogers; Daniel Gentry; Reannon Holland; Peter Demarsh; Kelly Aubart; Magdalena Zalacain
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

Review 7.  Antibiotics and bacterial resistance in the 21st century.

Authors:  Richard J Fair; Yitzhak Tor
Journal:  Perspect Medicin Chem       Date:  2014-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.